Open Access Open Access  Restricted Access Subscription Access

A Review on Amla (Emblica Officinalis) as Anti-Inflammatory, Anti-Diabetic, Anti-Cancer

Mr. Vivek K. Patil, Mr. Roshan M. Chaudhari, Mr. Hitendra S. Chaudhari, Dr. S. P. Pawar

Abstract


Linn’s Phyllanthus emblica. Alternatively, Emblica officinalis Gaertn, often known as Indian or gooseberry. Emblica Amla officinalis is frequently utilized in the medical system in India (Siddha, Unani and Ayurveda). Considering archaic theories it is the first tree in Indian mythology. To be produced in the cosmos. It is a member of the family of Euphorbiaceae. The wealthiest source of vitamin C naturally. Emblica officinalis (EO) mostly includes alkaloids, phenol and tannins, amino acids, compounds and carbohydrates. Fruit juice from it contains the greatest concentration of vitamin C Chebulinic acid, Ellagic acid, Chebulagic acid, quercetin, Gallic, Emblicanin-A and Emblicanin-B all components of the acid, Ascorbic acid, etc. Using amla in the treatment of a number of illnesses, but the most a crucial component is fruit.

The amla fruit when used alone or in combination with other herbs, is often used in Indian medicine as a diuretic, laxative, stomachic, tonic, hair tonic, restorative, and antipyretic to prevent ulcers, the common cold, and fever. The Fruit is a significant ingredient. A number of Ayurvedic remedies, including like Rasayana and Chyavanprash, which encourages lifespan and health. Routine consumption of Emblica officinalis increases resistance, fights off cancers, chronic illnesses such as high blood pressure, high cholesterol diabetes, the flu and a persistent cough and cold, persistent infections, persistent exhaustion and persistent inflammation conditions. In line with Ayurveda one of the greatest herbs for is amla. Diabetes, clotting issues and power and an energy promoter.


Full Text:

PDF

References


Singh E, Sharma S, Pareek A, Dwivedi J, Yadav S, Sharma S. Phytochemistry, traditional uses and cancer chemoprotective activity of Amla (Phyllanthus emblica): The sustainer. Journal of Applied Pharmaceutical Science, 2011; 02(01): 176-183.

Khan KH. Roles of Emblica officinalis in medicine – A Review. Botany Research International, 2009; 2 (4): 218-228.

Dnyaneshwar, W., C. Preeti, J. Kalpana and P. Bhushan, Development and application of RAPD-SCAR marker for identification of Phyllanthus emblica LINN. Biol Pharm Bull., 2006; 29(11): 2313-6.

Agnivesa, Cakrapani datta, Sharma RK, Dash VB; Agnivesa’s Caraka Samhita: Text with english translation & Critical exposition based on Cakrapani datta’s Ayurveda Dipika, 1st ed. Varanasi, India: Chowkhamba Sanskrit Series Office, 1976.

Srivasuki KP, Nutritional and health care benefits of Amla, Journal of Pharmacognosy, 2012; 3(2): 141-51.

Meena AK, Singh A and Rao MM. Evaluation of physicochemical and preliminary phytochemical studies on the fruit of Emblica officinalis Gaertn. Asian J. Pharma. And Clin. Res., 2010; 3(3): 242-243.

Thakur RS, Puri HS, Husain A, Major Medicinal Plants of India, Central Institute of Medicinal and Aromatic Plants, Lucknow, 1989; 24-27.

S. M. Hassan, S. S. Mughal, ana A. Aslam, ‘’Emblica Officinalis (Amla): A Prospective Review On Distinctive Properties And Therapeutic Applications Of Amla,’’ Biomedicine and Nursing, vol. 6, no. 2, pp. 22-30, 2020.

K. D. Moudgil and B. M. Berman, “Traditional Chinese medicine: potential for clinical treatment of rheumatoid arthritis,” Expert Review of Clinical Immunology, vol. 10, no. 7, pp. 819–822, 2014.

Z. Varga, M. Kriˇska, V. Kristov´a, and M. Petrov´a, “Analysis of non-steroidal anti-inflammatory drug use in hospitalized patients and perception of their risk,” Interdisciplinary Toxicology, vol. 6, no. 3, pp. 141–144, 2013.

E. Z. Dajani and K. Islam, “Cardiovascular and gastrointestinal Toxicity of selective cyclo-oxygenase-2 inhibitors in man,” Journal of Physiology and Pharmacology, vol. 59, no. 2, pp. 117–133, 2008.

T. Santiago and J. A. P. da Silva, “Safety of low- to mediumdose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years,” Annals of the New York Academy of Sciences, pp. 41–49, 2014.

Galib, B. Patgiri, and P. Prajapati, “Pharmacological attributes of Indian medicinal plants with special reference to their antiinflammatory activity,” Ancient Science of Life, vol. 28, no. 3, pp. 36–39, 2009.

M. J. Feeney, “Fruits and the prevention of lifestyle-related diseases,” Clinical and Experimental Pharmacology and Physiology, vol. 31, supplement 2, pp. S11–S13, 2004.

Dubois, R.N.; Abramson, S.B.; Crofford, L.; Gupta, R.A.; Simon, L.S.; Van De Putte, L.B.; Lipsky, P.E. Cyclooxygenase in biology and disease. FASEB J. 1998, 12, 1063–1073.

Hwang, S.-L.; Yen, G.-C. Neuroprotective effects of the citrus flavanones against H2O2-induced cytotoxicity in PC12 cells. J. Agric. Food Chem. 2008, 56, 859–864.

Rajalakshmi, S.; Vijayakumar, S.; Praseeth, P.K. Neuroprotective behaviour of Phyllanthus emblica (L) on human neural celllineage (PC12) against glutamate-induced cytotoxicity. Gene Rep. 2019, 17, 100545.

Gregg, E.; Buckley, J.; Ali, M.; Davies, J.; Flood, D.; Griffiths, B.; Lim, L.; Manne-Goehler, J.; Pearson-Stuttard, J.; Shaw, J. Improving Health Outcomes of People with Diabetes Mellitus: Target Setting to Reduce the Global Burden of Diabetes Mellitus by 2030; World Health Organization: Geneva, Switzerland, 2021; pp. 1–26.

Sun, H.; Saeedi, P.; Karuranga, S.; Pinkepank, M.; Ogurtsova, K.; Duncan, B.B.; Stein, C.; Basit, A.; Chan, J.C.N.; Mbanya, J.C.; et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022, 183, 109119.

Kim, J.A.; Wei, Y.; Sowers, J.R. Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 2008, 102, 401–414.

Pandey, M.; Rastogi, S.; Rawat, A. Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid. Based complement. Alternat. Med. 2013, 2013, 376327.

Saini, R.; Sharma, N.; Oladeji, O.S.; Sourirajan, A.; Dev, K.; Zengin, G.; El-Shazly, M.; Kumar, V. Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: A comprehensive review. J. Ethnopharmacol. 2022, 282, 114570.

Stumvoll, M.; Goldstein, B.J.; van Haeften, T.W. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet 2005, 365, 1333–1346.

Galicia-Garcia, U.; Benito-Vicente, A.; Jebari, S.; Larrea-Sebal, A.; Siddiqi, H.; Uribe, K.B.; Ostolaza, H.; Martín, C. Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci. 2020, 21, 6275.

J. Ferlay, I. Soerjomataram, R. Dikshit et al., “Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012,” International Journal of Cancer, vol. 136, no. 5, pp. E359–E386, 2015.

P. Hanly, I. Soerjomataram, and L. Sharp, “Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe,” International Journal of Cancer, vol. 136, no. 4, pp. E136–E45, 2015.

D. W. Unander, G. L. Webster, and B. S. Blumberg, “Record of usage or assays in Phyllanthus (Euphorbiaceae) I. Subgenera Isocladus, Kirganelia, Cicca and Emblica,” Journal of Ethnopharmacology, vol. 30, no. 3, pp. 233–264, 1990.

N. Sharma, P. Trikha, M. Athar, and S. Raisuddin, “In vitro inhibition of carcinogen-induced mutagenicity by Cassia occidentalis and Emblica officinalis,” Drug and Chemical Toxicology, Vol. 23, no. 3, pp. 477–484, 2000.

S. Sultana, S. Ahmed, and T. Jahangir, “Emblica officinalis and hepatocarcinogenesis: a chemopreventive study in Wistar rats,” Journal of Ethnopharmacology, vol. 118, no. 1, pp. 1–6, 2008.

B. Hazra, R. Sarkar, S. Biswas, and N. Mandal, “Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis,” BMC Complementary And Alternative Medicine, vol. 10, article 20, 2010.

M. Majeed, B. Bhat, A. N. Jadhav, J. S. Srivastava, and K. Nagabhushanam, “Ascorbic acid and tannins from Emblica officinalis Gaertn. Fruits—a revisit,” Journal of Agricultural and Food Chemistry, vol. 57, no. 1, pp. 220–225, 2009.

S. M. Banu, K. Selvendiran, J. P. V. Singh, and D. Sakthisekaran,“Protective effect of Emblica officinalis ethanolic extract against 7,12-dimethylbenz(a)anthracene (DMBA) induced genotoxicity in Swiss albino mice,” Human and Experimental Toxicology, vol.23, no. 11, pp. 527–531, 2004.

C. Wiart, “Note on the relevance of Emblica officinalis Gaertn. For the treatment and prevention of cancer,” European Journal of Cancer Prevention, vol. 22, no. 2, article 198, 2013.

Bafna P. A. and R. Balaraman, Anti-ulcer and anti-oxidant activity of pepticare, a herbomineral formulation. Phytomedicine, 2005; 12(4): 264-70.

Sairam, K., C.V. Rao, M.D. Babu, K.V. Kumar, V.K. Agrawal and R.K. Goel, antiulcerogenic effect of methanolic extract of Emblica officinalis: an experimental study. J Ethnopharmacol, 2002; 82(1): 1-9.

Jain SK. Medicianl Plants, National Book Trust, New Delhi, 1968.

Udupa KN. Ayurveda for Promotion of Health, Journal of Ayurveda, 1985; 3.

Prakash D, Upadhyay G, Gupta C, Pushpangadan P and Singh KK. Antioxidant and free radical scavenging activities of some promising wild edible fruits. Int. Food Res. J., 2012; 19 (3): 1109-1116.

Chaieb I. Saponins as insecticides: a review. Tunisian J. Plant Prot. 2010; 5: 39-50.


Refbacks

  • There are currently no refbacks.